29/07/2026
"The Headlines Didn't Tell You This."
There's been a lot of discussion lately about ivermectin and mebendazole as potential cancer treatments. Naturally, many patients have been asking us about it.
Here's what you should know. ⬇️
⁉️ The study making headlines was not a controlled clinical trial. It did not include verified scans, imaging, biopsies, or other objective measures to confirm outcomes. Instead, it relied on patient surveys, and many of those patients were also receiving chemotherapy, radiation, surgery, or other proven cancer treatments. That means we cannot determine what actually led to any reported improvement.
⚠️ Another important detail that isn't making the headlines: the authors reported financial relationships with the company selling the ivermectin and mebendazole products used in the study.
➡️ Conflicts of interest don't automatically invalidate research, but they do mean the findings should be interpreted with caution and independently verified.
Research in the laboratory can be exciting, but what works in a petri dish doesn't always work safely or effectively in people. At this stage, there is no high-quality clinical evidence proving these medications treat or prevent cancer in humans.
Hope is important. So is evidence.
Before making any changes to your cancer treatment or adding new medications, speak with your physician or oncology team. Your treatment decisions should be based on the best available medical evidence—not just headlines.
Questions? We're here to help.
Grand Harbour Medical
949-4309
